CAS No. 62096-52-0

Indeno[2,1-b]pyran, 4,9-dimethyl-2-phenyl-

Catalog No.: 553992
Name: Indeno[2,1-b]pyran, 4,9-dimethyl-2-phenyl-
CAS: 62096-52-0
Formula: C20H16O

Filed under: Pyran, Indeno, [2,1-b]

Inquire about this product → | Safety data

About Indeno[2,1-b]pyran, 4,9-dimethyl-2-phenyl-

Indeno[2,1-b]pyran, 4,9-dimethyl-2-phenyl- is a chemical compound registered under CAS number 62096-52-0, with the molecular formula C20H16O and a molecular weight of about 272.34 g/mol. 9CMX supplies Indeno[2,1-b]pyran, 4,9-dimethyl-2-phenyl- for laboratory research and bulk production; product code 553992. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 62096-52-0
Molecular Formula: C20H16O
Molecular Weight: 272.34 g/mol

Related Keywords

pyran

indeno

Indeno

Pyran

2-Butanone, 4-hydroxy-4-[4-(trifluoromethyl)phenyl]-

2-Buten-1-aminium, 2-chloro-N,N,N-tris(2-hydroxyethyl)-4-phenoxy-,bromide

2H-Isoindol-2-yloxy, 1,3-dihydro-1,3-dioxo-4,5,6,7-tetraphenyl-

Propanamide,N-[1-[4-(4-fluorophenyl)-4-oxobutyl]decahydro-4-quinolinyl]-N-(4-methylphenyl)-, monohydrochloride

2H-Indol-2-one,3-[5-[3-(diethylamino)propoxy]-1(3H)-isobenzofuranylidene]-5-fluoro-1,3-dihydro-

4-(acetylethylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid

802904-95-6

2-Butanone,[(4-chlorophenyl)[4-[(methylsulfonyl)oxy]phenyl]methylene]hydrazone

2H-Indol-2-one,5-acetyl-3-[1,3-benzodioxol-5-yl[(tetrahydro-1,1-dioxido-3-thienyl)amino]methylene]-1,3-dihydro-, (3Z)-

3-Quinolinecarboxylic acid,6,7-dimethoxy-4-(4-methoxyphenyl)-2-(4-morpholinylmethyl)-, ethyl ester

2H-Indol-2-one,5-chloro-3-[[2-chloro-5-methoxy-6-methyl-1-(phenylmethyl)-1H-indol-3-yl]methylene]-1,3-dihydro-, (3E)-

Hydrazinecarboxamide,2-[1-(3-bromophenyl)-2-(4-morpholinyl)-2-oxoethylidene]-N-[4-(trifluoromethoxy)phenyl]-

2-Buten-1-ol, 3-[1-(phenylmethyl)-1H-indol-7-yl]-, (2E)-

617711-25-8

2H-Indol-2-one,5-acetyl-3-[(3,4-dimethoxyphenyl)[[4-[(ethylamino)methyl]phenyl]amino]methylene]-1,3-dihydro-, (3Z)-, mono(trifluoroacetate)

2-Buten-1-ol, 2,3-dimethyl-

[1,1'-Biphenyl]-2-sulfonamide,4'-[[1-(2-bromo-5-nitrophenyl)-3-butyl-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]methyl]-N-(1,1-dimethylethyl)-

2H-Indol-2-one,5-acetyl-3-[[(1-ethyl-3-piperidinyl)amino]phenylmethylene]-1,3-dihydro-,(3Z)-

2H-Indol-2-one,5-acetyl-3-[[[trans-4-(dimethylamino)cyclohexyl]amino][4-(trifluoromethyl)phenyl]methylene]-1,3-dihydro-, (3Z)-

2-Buten-1-amine, 2-methyl-, (Z)-

104131-80-8

Piperazine,1-(cyclohexylmethyl)-4-[4-[(2,3-dihydro-2-oxo-1H-pyrrolo[2,3-b]quinolin-6-yl)oxy]-1-oxobutyl]-, dihydrochloride

2-Butanone,1-[1-(3,5-dichloro-4-methoxyphenyl)cyclobutyl]-1-(dimethylamino)-,hydrochloride

1-bromo-4,5-dimethoxy-2-[(E)-2-nitroethenyl]benzene

2H-Indol-2-one,5-chloro-3-[[4-(4-chlorophenyl)-6-(4-methylphenyl)-2-pyrimidinyl]imino]-1,3-dihydro-

2H-Indol-2-one,5-acetyl-3-[1,3-benzodioxol-5-yl[[4-[2-(dimethylamino)ethoxy]cyclohexyl]amino]methylene]-1,3-dihydro-, (3Z)-

2H-Indol-2-one,5-acetyl-1,3-dihydro-3-[[(1-methyl-4-piperidinyl)amino][4-(1H-pyrrol-1-yl)phenyl]methylene]-, (3Z)-

864688-34-6

2H-Indol-2-one,5-acetyl-3-[1-[[5-(dimethylamino)pentyl]amino]hexylidene]-1,3-dihydro-

2-Buten-1-ol, 3-methyl-4-nitro-, acetate (ester), (Z)-

6-Quinazolinol, 2-(4-hydroxyphenyl)-4-(4-morpholinyl)-

Carbamic acid,[2-[6-[(hydroxyimino)methyl]-1,3-benzodioxol-5-yl]ethyl]methyl-, ethylester

2H-Indol-2-one,5-fluoro-1,3-dihydro-3-[[5-methyl-4-(methylsulfonyl)-3-phenyl-1H-pyrrol-2-yl]methylene]-, (3Z)-

2H-Indol-2-one,4-chloro-1-[2-(diethylamino)ethyl]-1,3-dihydro-3-hydroxy-6-(3-hydroxy-1-propynyl)-3-(2-naphthalenyl)-

259666-39-2

2-Buten-1-ol,3-[2,6-bis(1-methylethyl)-3-(2,2,2-trifluoroethoxy)-4-pyridinyl]-, (2Z)-

2H-Indol-2-one,5-acetyl-3-[1-[[5-(dimethylamino)pentyl]amino]pentylidene]-1,3-dihydro-

(R)-2-Bromopropan-1-ol

2H-Indol-2-one,5-acetyl-1,3-dihydro-3-[[[trans-4-[(2-oxo-1-pyrrolidinyl)methyl]cyclohexyl]amino]phenylmethylene]-, (3Z)-

Pyridine, 2-methoxy-6-tetradecyl-

Carbamic acid,[2-[methyl(2-methyl-1-phenylpropyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-, 1,1-dimethylethyl ester